AnalystsTony ButlerTony Butler's Stock Forecasts
AnalystsTony Butler
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4071 out of 4227 analysts
Average Return
-10.09%
Win Rate
31%25 out of 80
Risk vs Reward
Poor
Good
Tony Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
In8bio IncINAB | +117.83% | $1.29 | $2.81 | 2023-04-17 - 2023-05-26 | Strong Buy |
In8bio IncINAB | +116.15% | $1.30 | $2.81 | 2023-03-31 - 2023-05-26 | Strong Buy |
Translate Bio IncTBIO1 | +113.12% | $17.76 | $37.85 | 2021-03-18 - 2021-08-04 | Strong Buy |
In8bio IncINAB | +105.11% | $1.37 | $2.81 | 2023-03-29 - 2023-05-26 | Strong Buy |
Apexigen IncAPGN | +62.46% | $0.36 | $0.58 | 2023-05-16 - 2023-05-24 | Strong Buy |
Tony Butler Analyst Color
Get additional color on Tony Butler's coverage of popular stocks
Tony Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agenus IncAGEN | 2 | Strong Buy | $8.30 | +472.41% | Reiterates | 2 days ago |
Apexigen IncAPGN | 4 | Hold | $0.64 | +18.52% | Reiterates | 2 days ago |
Compugen LtdCGEN | 4 | Strong Buy | $13.00 | +1,126.42% | Reiterates | 2 days ago |
Aravive IncARAV | 4 | Strong Buy | $10.00 | +532.91% | Reiterates | 2 days ago |
Replimune Group IncREPL | 2 | Strong Buy | $60.00 | +207.85% | Reiterates | 2 days ago |
Adaptimmune Therapeutics PLCADAP | 5 | Strong Buy | $10.00 | +800.90% | Reiterates | 2 days ago |
Allogene Therapeutics IncALLO | 5 | Strong Buy | $15.00 | +171.25% | Reiterates | 2 days ago |
Ocean Biomedical IncOCEA | 1 | Strong Buy | $17.00 | +228.82% | Assumes | 3 days ago |
Rain Oncology IncRAIN | 5 | Hold | $5.00 | +354.55% | Downgrades | 5 days ago |
Gt Biopharma IncGTBP | 4 | Hold | $2.00 | +596.86% | Reiterates | 12 days ago |
Bioatla IncBCAB | 5 | Strong Buy | $25.00 | +709.06% | Reiterates | 16 days ago |
Bicycle Therapeutics PLCBCYC | 4 | Strong Buy | $55.00 | +127.09% | Reiterates | a month ago |
Merus NvMRUS | 5 | Strong Buy | $35.00 | +68.92% | Reiterates | a month ago |
Century Therapeutics IncIPSC | 4 | Strong Buy | $16.00 | +428.05% | Maintains | a month ago |
In8bio IncINAB | 3 | Strong Buy | $8.00 | +184.70% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $75.00 | +15.99% | Reiterates | a month ago |
Atreca IncBCEL | 2 | Strong Buy | $10.00 | +875.61% | Reiterates | 2 months ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $2.00 | +26.58% | Reiterates | 2 months ago |
Cel Sci CorpCVM | 2 | Strong Buy | $10.00 | +301.61% | Reiterates | 3 months ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | +94.93% | Reiterates | 3 months ago |
G1 Therapeutics IncGTHX | 3 | Strong Buy | $19.00 | +625.19% | Maintains | 3 months ago |
Atara Biotherapeutics IncATRA | 1 | Strong Buy | $25.00 | +1,312.43% | Initiates Coverage On | 5 months ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | +149.38% | Initiates Coverage On | 5 months ago |
Ayala Pharmaceuticals IncAYLA | 2 | Strong Sell | $0.55 | +9.13% | Downgrades | 7 months ago |
Humanigen IncHGEN | 2 | Hold | $2.00 | +1,233.33% | Downgrades | 10 months ago |
Marker Therapeutics IncMRKR | 2 | Hold | $10.00 | N/A | Downgrades | a year ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Translate Bio IncTBIO1 | 3 | Hold | $38.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $110.00 | N/A | Maintains | 2 years ago |
Panbela Therapeutics IncPBLA | 1 | Strong Buy | $400.00 | N/A | Initiates Coverage On | 2 years ago |
Nextcure IncNXTC | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Arqule IncARQL | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.